These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19840258)
1. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Lu SN; Chen CJ Liver Int; 2010 Mar; 30(3):423-9. PubMed ID: 19840258 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774 [TBL] [Abstract][Full Text] [Related]
3. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ; Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048 [TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B REVEALed. Chen CJ; Yang HI J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729 [TBL] [Abstract][Full Text] [Related]
5. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ; Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450 [TBL] [Abstract][Full Text] [Related]
6. Risk and predictors of mortality associated with chronic hepatitis B infection. Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ; Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B e antigen and the risk of hepatocellular carcinoma. Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ; N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405 [TBL] [Abstract][Full Text] [Related]
9. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ; Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214 [TBL] [Abstract][Full Text] [Related]
10. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]. Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556 [TBL] [Abstract][Full Text] [Related]
11. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study. Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124 [TBL] [Abstract][Full Text] [Related]
14. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B. Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290 [TBL] [Abstract][Full Text] [Related]
15. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Wang CS; Yao WJ; Chang TT; Wang ST; Chou P Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812 [TBL] [Abstract][Full Text] [Related]
16. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840 [TBL] [Abstract][Full Text] [Related]
17. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669 [TBL] [Abstract][Full Text] [Related]
18. The long-term course of chronic hepatitis B. Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664 [TBL] [Abstract][Full Text] [Related]
19. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378 [TBL] [Abstract][Full Text] [Related]
20. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan. Fwu CW; Chien YC; Nelson KE; Kirk GD; You SL; Kuo HS; Feinleib M; Chen CJ J Infect Dis; 2010 Apr; 201(7):1016-23. PubMed ID: 20187745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]